Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for EyesVision Corporation (031310:KRX), powered by AI.
EyesVision Corporation is currently trading at ₩2,175. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for EyesVision Corporation on Alpha Lenz.
EyesVision Corporation's P/E ratio is -36.0.
“EyesVision Corporation trades at a P/E of -36.0 (undervalued) with modest ROE of -1.0%.”
Ask for details →EyesVision Corporation is a prominent player in the healthcare sector, specifically focusing on the development and manufacturing of advanced ophthalmic products. The company's primary function is to innovate and deliver cutting-edge solutions for eye care, including diagnostic technologies and therapeutic treatments. EyesVision's products cater to a broad range of eye conditions, impacting both preventative care and advanced medical interventions. The corporation works closely with ophthalmologists, clinics, and healthcare facilities to ensure that their offerings meet the evolving needs of the industry and adhere to rigorous regulatory standards. A key characteristic of EyesVision is its commitment to research and development, which positions it at the forefront of new technologies and treatment methodologies that enhance visual health. In the financial market, EyesVision Corporation plays a crucial role by contributing to the healthcare and life sciences sectors, and its initiatives often influence trends in medical technology and patient care. Through its innovative approach, EyesVision supports the global endeavor to improve eye health and access to quality ophthalmic care.
“EyesVision Corporation trades at a P/E of -36.0 (undervalued) with modest ROE of -1.0%.”
Ask for details →EyesVision Corporation (ticker: 031310) is a company listed on KRX in the Common Stock sector (Common Stock). Market cap is $57.3B.
The current price is ₩2,175 with a P/E ratio of -36x and P/B of 0.34x.
ROE is -0.99% and operating margin is 0.56%. Annual revenue is $182.8B.